Yifan Zhai

CIK: 0002123017

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (20.0%)

Derivative conversions

Awards (A)8 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 21, 2026
Exercise(M)
Direct
92.7K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 21, 2026
Exercise(M)
Indirect
95.6K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Restricted stock units
Direct
103.4K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Restricted stock units
Direct
215K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Options
Direct
215K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Options
Direct
103.4K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Restricted stock units
Direct
92.7K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Restricted stock units
Indirect
95.6K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Restricted stock units
Indirect
298.2K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Options
Indirect
298.2K shares-

		Type	Shares	Price		Ownership
May 21, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Exercise(M)	92,746	-	$0	Direct
May 21, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Exercise(M)	95,575	-	$0	Indirect
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Restricted stock units	103,365	-	-	Direct
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Restricted stock units	214,999	-	-	Direct
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Options	214,988	-	-	Direct
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Options	103,364	-	-	Direct
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Restricted stock units	92,746	-	-	Direct
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Restricted stock units	95,575	-	-	Indirect
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Restricted stock units	298,195	-	-	Indirect
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Options	298,194	-	-	Indirect

1-10 of 10 transactions

About Zhai Yifan

Zhai Yifan (SEC CIK 0002123017) files insider reports with the SEC as Chief Medical Officer of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG).

Signal8 holds 2 ownership filings by Zhai Yifan (1 Form 3, 1 Form 4), filed between Mar 23, 2026 and May 22, 2026. Those filings report 10 transactions, from May 20, 2026 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Zhai Yifan's filings is in ROCKVILLE, MD.

Recent filings by Zhai Yifan

May 21, 2026: Option exercises of AAPG shares (2 lines, Form 4, code M).
May 20, 2026: Grants or awards of AAPG derivative securities (8 lines, Form 4, code A).

Other insiders filing for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)

Miyara Faical, Chief Business Officer
Yang Dajun, Chairman and CEO
Misra Veet, Chief Financial Officer
Cao Jin, Chief Accounting Officer
Wei Ren, Director
Ye Changqing, Director

How to read Form 4 transaction codes